Information Provided By: 
Fly News Breaks for January 8, 2019
DVA
Jan 8, 2019 | 05:36 EDT
UBS analyst Whit Mayo upgraded DaVita to Neutral from Sell while lowering his price target for the shares to $59 from $64. The recent weakness in the shares drives a better risk/reward profile, Mayo tells investors in a research note. The analyst, however, continues to sees structural concerns with payer mix and points out that record industry capacity is for sale.
News For DVA From the Last 2 Days
There are no results for your query DVA
